Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 50.19

+1.8%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (3993)	6/6/2001 1:01:30 AM
From: Larry Liebman	of 52153

I appreciate the input on my MYGN vs. HGSI dilemma. I think the valuation is the sticking point. HGSI ($9.2 billion) vs. MYGN ($1.8 billion). Is HGSI worth 5x the valuation of MYGN? Maybe not. Perhaps the $$$ is best deployed to REGN, CBST, PRCS, NBIX, and LEXG. Oh, well, let's see what news appears tomorrow.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next